StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle Appointments

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jan 24, 2022 6:14pm

125 Views

Post# 34355674

RE:RE:Aristotle Appointments

Six years of lost opportunity costs.

Pacman28 wrote:
tik tok tik tok.. if they are indeed selling Aristotle tests. the SP will turn around fast in my opinion. That's what I've invested in for the last 6yrs

<< Previous

Bullboard Posts

Next >>

Shopify stock hits year-high on Q3 results